Cryo Cell International (CCEL) Asset Writedowns and Impairment (2010 - 2026)
Cryo Cell International (CCEL) posted quarterly Asset Writedowns and Impairment of $320783.0 for Q2 2026, up 236.32% year-over-year from $95379.0 in Q2 2025, and up 50.36% quarter-over-quarter from $213341.0 in Q1 2026.
Powered by 
Analysis
Cryo Cell International (CCEL) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Asset Writedowns and Impairment for 17 consecutive years, with $320783.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment rose 236.32% year-over-year to $320783.0; the TTM figure through May 2026 stood at $5.3 million (up 632.07% YoY), while the FY2025 annual figure was $4.4 million, up 244.05% from the prior year.
- Asset Writedowns and Impairment improved to $320783.0 in Q2 2026 per CCEL's latest filing, from $213341.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $4.4 million in Q4 2025 and bottomed at $95379.0 in Q2 2025.
- Historically, Asset Writedowns and Impairment has averaged $730014.6 across 5 years, with a median of $271323.5 in 2024.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment jumped 1533.03% — and 2025, when it tumbled 64.86%.
- Cryo Cell International's Asset Writedowns and Impairment stood at $234452.0 in 2022, then surged by 1493.99% to $3.7 million in 2023, then slumped by 90.41% to $358288.0 in 2024, then surged by 1116.57% to $4.4 million in 2025, then sank by 92.64% to $320783.0 in 2026.
- Business Quant data shows CCEL's Asset Writedowns and Impairment at $320783.0 in Q2 2026, $213341.0 in Q1 2026, and $4.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn |
| 10 | Cryo Cell International | 32.55 Mn | 29.39 Mn | 6.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 320,783.00 |
| Feb 28, 2026 | 213,341.00 |
| Nov 30, 2025 | 4.36 Mn |
| Aug 31, 2025 | 413,611.00 |
| May 31, 2025 | 95,379.00 |
| Feb 28, 2025 | 271,207.00 |
| Aug 31, 2024 | 358,288.00 |
| May 31, 2024 | 271,440.00 |
| Feb 29, 2024 | 288,760.00 |
| Nov 30, 2023 | 151,743.00 |
| Aug 31, 2023 | 314,012.00 |
| May 31, 2023 | 216,136.00 |
| Feb 28, 2023 | 186,904.00 |
| Aug 31, 2022 | 234,452.00 |
| May 31, 2022 | 235,565.00 |
| Feb 28, 2022 | 164,388.00 |
| Nov 30, 2021 | 1.16 Mn |
| Aug 31, 2021 | 166,181.00 |
| May 31, 2021 | 14,425.00 |
| Feb 28, 2021 | 90,854.00 |